122 related articles for article (PubMed ID: 3558361)
1. Characterization of the catalytic defect in the dysthrombin, Thrombin Quick.
Henriksen RA; Owen WG
J Biol Chem; 1987 Apr; 262(10):4664-9. PubMed ID: 3558361
[TBL] [Abstract][Full Text] [Related]
2. Substitution of valine for glycine-558 in the congenital dysthrombin thrombin Quick II alters primary substrate specificity.
Henriksen RA; Mann KG
Biochemistry; 1989 Mar; 28(5):2078-82. PubMed ID: 2719946
[TBL] [Abstract][Full Text] [Related]
3. Identification of the primary structural defect in the dysthrombin thrombin Quick I: substitution of cysteine for arginine-382.
Henriksen RA; Mann KG
Biochemistry; 1988 Dec; 27(26):9160-5. PubMed ID: 3242619
[TBL] [Abstract][Full Text] [Related]
4. The effect of bovine thrombomodulin on the specificity of bovine thrombin.
Jakubowski HV; Kline MD; Owen WG
J Biol Chem; 1986 Mar; 261(8):3876-82. PubMed ID: 3005304
[TBL] [Abstract][Full Text] [Related]
5. Identification of a congenital dysthrombin, thrombin Quick.
Henriksen RA; Owen WG; Nesheim ME; Mann KG
J Clin Invest; 1980 Nov; 66(5):934-40. PubMed ID: 6776145
[TBL] [Abstract][Full Text] [Related]
6. Evidence that activation of platelets and endothelium by thrombin involves distinct sites of interaction. Studies with the dysthrombin, Thrombin Quick I.
Henriksen RA; Brotherton AF
J Biol Chem; 1983 Nov; 258(22):13717-21. PubMed ID: 6358210
[TBL] [Abstract][Full Text] [Related]
7. Alpha-thrombin-catalyzed hydrolysis of fibrin I. Alternative binding modes and the accessibility of the active site in fibrin I-bound alpha-thrombin.
Naski MC; Shafer JA
J Biol Chem; 1990 Jan; 265(3):1401-7. PubMed ID: 2295636
[TBL] [Abstract][Full Text] [Related]
8. The role of thrombin's Tyr-Pro-Pro-Trp motif in the interaction with fibrinogen, thrombomodulin, protein C, antithrombin III, and the Kunitz inhibitors.
Le Bonniec BF; Guinto ER; MacGillivray RT; Stone SR; Esmon CT
J Biol Chem; 1993 Sep; 268(25):19055-61. PubMed ID: 8395526
[TBL] [Abstract][Full Text] [Related]
9. Role of the thrombin insertion loop 144-155. Study of thrombin mutations W148G, K154E and a thrombin-based synthetic peptide.
Bouton MC; Plantier JL; Dembak M; Guillin MC; Rabiet MJ; Jandrot-Perrus M
Eur J Biochem; 1995 Apr; 229(2):526-32. PubMed ID: 7744076
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of human thrombin assessed with different substrates and inhibitors. Characterization of fibrinopeptide binding interaction.
Gorman JJ
Biochim Biophys Acta; 1975 Dec; 412(2):273-82. PubMed ID: 1191680
[TBL] [Abstract][Full Text] [Related]
11. Formation of a ternary complex between thrombin, fibrin monomer, and heparin influences the action of thrombin on its substrates.
Hogg PJ; Jackson CM
J Biol Chem; 1990 Jan; 265(1):248-55. PubMed ID: 2294105
[TBL] [Abstract][Full Text] [Related]
12. Thrombin specificity with tripeptide chromogenic substrates: comparison of human and bovine thrombins with and without fibrinogen clotting activities.
Sonder SA; Fenton JW
Clin Chem; 1986 Jun; 32(6):934-7. PubMed ID: 3708816
[TBL] [Abstract][Full Text] [Related]
13. Difference in enzymatic properties between alpha-thrombin-staphylocoagulase complex and free alpha-thrombin.
Kawabata S; Morita T; Iwanaga S; Igarashi H
J Biochem; 1985 Apr; 97(4):1073-8. PubMed ID: 4030715
[TBL] [Abstract][Full Text] [Related]
14. Effects of protons on the thrombin-fibrinogen interaction.
Picozzi M; Landolfi R; De Cristofaro R
Eur J Biochem; 1994 Feb; 219(3):1013-21. PubMed ID: 8112314
[TBL] [Abstract][Full Text] [Related]
15. The thrombin high-affinity binding site on platelets is a negative regulator of thrombin-induced platelet activation. Structure-function studies using two mutant thrombins, Quick I and Quick II.
Leong L; Henriksen RA; Kermode JC; Rittenhouse SE; Tracy PB
Biochemistry; 1992 Mar; 31(9):2567-76. PubMed ID: 1547239
[TBL] [Abstract][Full Text] [Related]
16. The action of thrombin on peptide p-nitroanilide substrates: hydrolysis of Tos-Gly-Pro-Arg-pNA and D-Phe-Pip-Arg-pNA by human alpha and gamma and bovine alpha and beta-thrombins.
Lottenberg R; Hall JA; Fenton JW; Jackson CM
Thromb Res; 1982 Nov; 28(3):313-32. PubMed ID: 7179220
[TBL] [Abstract][Full Text] [Related]
17. Design and characterization of hirulogs: a novel class of bivalent peptide inhibitors of thrombin.
Maraganore JM; Bourdon P; Jablonski J; Ramachandran KL; Fenton JW
Biochemistry; 1990 Jul; 29(30):7095-101. PubMed ID: 2223763
[TBL] [Abstract][Full Text] [Related]
18. Active-site mapping of bovine and human blood coagulation serine proteases using synthetic peptide 4-nitroanilide and thio ester substrates.
Cho K; Tanaka T; Cook RR; Kisiel W; Fujikawa K; Kurachi K; Powers JC
Biochemistry; 1984 Feb; 23(4):644-50. PubMed ID: 6370301
[TBL] [Abstract][Full Text] [Related]
19. Thrombin Metz: characterization of the dysfunctional thrombin derived from a variant of human prothrombin.
Rabiet MJ; Jandrot-Perrus M; Boissel JP; Elion J; Josso F
Blood; 1984 Apr; 63(4):927-34. PubMed ID: 6546700
[TBL] [Abstract][Full Text] [Related]
20. Substitution of Gly-548 to Ala in the substrate binding pocket of prothrombin Perijá leads to the loss of thrombin proteolytic activity.
Sekine O; Sugo T; Ebisawa K; Umeyama H; Iwahana H; Ruiz-Sáez A; de Bosch N; Matsudai M
Thromb Haemost; 2002 Feb; 87(2):282-7. PubMed ID: 11858488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
